IPP Bureau
Themis Medicare launches Lenzetto for treatment of menopausal symptoms
By IPP Bureau - January 04, 2023
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
BDR Pharmaceutical launches the first generic to treat Prostate cancer in India
By IPP Bureau - January 04, 2023
BDRs journey for the treatment of Prostate Cancer started with Abiratarone Acetate, then Leuprolide Acetate followed by Enzalutamide and, then Degarelix and Triptorelin.
Harbor Healthcare advises a California long-term care pharmacy on its sale & strategic partnership
By IPP Bureau - January 04, 2023
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
CNS Pharmaceuticals appoints Faith L. Charles as Chair of the Board of Directors
By IPP Bureau - January 04, 2023
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
Blacksmith announces merger with Forge Therapeutics
By IPP Bureau - January 03, 2023
To create leading company developing medicines targeting metalloenzymes
‘SMART’ program for Ayurveda professionals to boost research in Ayurveda
By IPP Bureau - January 03, 2023
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Mandaviya reviews arrangements for screening and testing of international passengers
By IPP Bureau - January 03, 2023
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
Polysciences announces new bioprocessing brand ‘Kyfora Bio’
By IPP Bureau - January 03, 2023
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Granules partners with Greenko ZeroC to enable green molecule solutions
By IPP Bureau - January 03, 2023
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
MoU signed for commercial production of indigenously developed vaccine ‘Lumpi-ProVac’
By IPP Bureau - January 02, 2023
Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year
Survival Technologies files DRHP with SEBI for Rs 1,000 crore IPO
By IPP Bureau - January 02, 2023
The company is one of the most profitable companies manufacturing speciality chemicals in India
Quantori partners with Databricks to accelerate data-driven innovation in life sciences
By IPP Bureau - January 02, 2023
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
Briefs: Kilitch Drugs India, Family Care Hospitals and Krishna Institute of Medical Sciences
By IPP Bureau - January 01, 2023
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
Aster DM Healthcare inks O&M agreement to operate hospital in Mandya
By IPP Bureau - January 01, 2023
The term of O&M is for 15 years with a lock in period of 5 years for the Company and 15 years for VHPL & Bharathi Education trust.
Zydus receives final approval from USFDA for Triazolam Tablets
By IPP Bureau - December 31, 2022
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
